Literature DB >> 15094061

Elucidation of CPX-1 involvement in RANKL-induced osteoclastogenesis by a proteomics approach.

Eun-Ju Chang1, Han Bok Kwak, Hyunsoo Kim, Joo-Cheol Park, Zang Hee Lee, Hong-Hee Kim.   

Abstract

To identify proteins potentially involved in osteoclast differentiation, we conducted a proteomics-based analysis using the osteoclastogenesis model cell line RAW264.7. Total proteins from undifferentiated cells, committed pre-osteoclasts, and differentiated osteoclasts were resolved by two-dimensional gel electrophoresis. Protein spots showing differential expression levels were processed for peptide mass fingerprinting. Among them, we identified the metallocarboxypeptidase CPX-1, which was prominently increased in pre-osteoclasts and then decreased in mature osteoclasts. Results of reverse transcription polymerase chain reaction, Western blot, and confocal microscopy were in agreement with the proteomics data. Notably, the forced overexpression of CPX-1 led to the inhibition of osteoclast formation, but not pre-osteoclast generation. Therefore, the transient up-regulation pattern of CPX-1 expression may be important for the successful progression from pre-osteoclasts to mature osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094061     DOI: 10.1016/S0014-5793(04)00338-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Proteomic analysis of gingival tissue and alveolar bone during alveolar bone healing.

Authors:  Hee-Young Yang; Joseph Kwon; Min-Suk Kook; Seong Soo Kang; Se Eun Kim; Sungoh Sohn; Seunggon Jung; Sang-Oh Kwon; Hyung-Seok Kim; Jae Hyuk Lee; Tae-Hoon Lee
Journal:  Mol Cell Proteomics       Date:  2013-07-03       Impact factor: 5.911

2.  Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.

Authors:  Natsue Uehiro; Fumiaki Sato; Fengling Pu; Sunao Tanaka; Masahiro Kawashima; Kosuke Kawaguchi; Masahiro Sugimoto; Shigehira Saji; Masakazu Toi
Journal:  Breast Cancer Res       Date:  2016-12-19       Impact factor: 6.466

3.  Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.

Authors:  Katja Grabowski; Laura Herlan; Anika Witten; Fatimunnisa Qadri; Andreas Eisenreich; Diana Lindner; Martin Schädlich; Angela Schulz; Jana Subrova; Ketaki Nitin Mhatre; Uwe Primessnig; Ralph Plehm; Sophie van Linthout; Felicitas Escher; Michael Bader; Monika Stoll; Dirk Westermann; Frank R Heinzel; Reinhold Kreutz
Journal:  Hypertens Res       Date:  2021-12-16       Impact factor: 3.872

4.  Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences.

Authors:  Orsolya Tünde Kovács; Eszter Tóth; Olivér Ozohanics; Eszter Soltész-Katona; Nikolett Marton; Edit Irén Buzás; László Hunyady; László Drahos; Gábor Turu; György Nagy
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.